secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K
Filed at:   2024-01-18T23:59:59+00:00
Accession:  0001193125-24-010226
Event type: other
Sentiment:  positive
Materiality: 0.35
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Spyre Therapeutics transfers listing to Nasdaq Global Select Market effective Jan 19, 2024
--------------------------------------------------------------------------------

- Received approval from Nasdaq to transfer listing from Capital Market to Global Select Market.
- Effective at the opening of business on January 19, 2024.
- Common stock continues to trade under the symbol SYRE.
- Transfer indicates the company met stricter financial requirements for higher-tier market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000119312524010226/0001193125-24-010226-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000119312524010226/d700531d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-010226

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer